Turn recording back on
Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.
Hayden MR, Tyagi SC.
Cardiovasc Diabetol. 2002 Sep 27;1:3.
PMID: 12392600 [PubMed]
Related Articles Free article in PMC
Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
JOP. 2002 Jul;3(4):86-108. Review.
PMID: 12110767 [PubMed - indexed for MEDLINE]
Related Articles
Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.
Cardiovasc Diabetol. 2003 Feb 12;2:2.
PMID: 12628022 [PubMed]
Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation.
Cardiovasc Diabetol. 2004 Feb 4;3:1.
PMID: 14761253 [PubMed]
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.
Nutr Metab (Lond). 2004 Oct 19;1(1):10.
PMID: 15507132 [PubMed - as supplied by publisher]
Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation.
Nutr J. 2004 May 10;3:4.
PMID: 15134582 [PubMed]
Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy.
Med Sci Monit. 2004 Dec;10(12):RA291-307. Review.
PMID: 15567993 [PubMed - indexed for MEDLINE]
Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure.
Med Sci Monit. 2003 Jul;9(7):SR35-52. Review.
PMID: 12883468 [PubMed - indexed for MEDLINE]
Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.
Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R.
Cardiovasc Diabetol. 2005 Mar 18;4(1):4. Review.
PMID: 15777477 [PubMed - indexed for MEDLINE]
Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
Venkatapuram S, Shannon RP.
Am J Ther. 2006 Jan-Feb;13(1):64-71. Review.
PMID: 16428924 [PubMed - indexed for MEDLINE]
Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.
Hayden MR, Whaley-Connell A, Sowers JR.
Am J Nephrol. 2005 Nov-Dec;25(6):553-69. Review.
PMID: 16210838 [PubMed - indexed for MEDLINE]
Insulin resistance and the endothelium.
Quiñones MJ, Nicholas SB, Lyon CJ.
Curr Diab Rep. 2005 Aug;5(4):246-53. Review.
PMID: 16033673 [PubMed - indexed for MEDLINE]
Type 2 diabetes mellitus as a conformational disease.
Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR.
JOP. 2005 Jul 8;6(4):287-302. Review.
PMID: 16006679 [PubMed - indexed for MEDLINE]
Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA, Lewanczuk RZ.
Am J Hypertens. 2005 Jan;18(1):121-8. Review.
PMID: 15691626 [PubMed - indexed for MEDLINE]
Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus.
Gazzaruso C, Solerte SB, De Amici E, Mancini M, Pujia A, Fratino P, Giustina A, Garzaniti A.
Am J Cardiol. 2006 Jan 15;97(2):236-9. Epub 2005 Dec 1.
PMID: 16442369 [PubMed - indexed for MEDLINE]
Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications.
Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR.
Curr Mol Med. 2006 Aug;6(5):501-14. Review.
PMID: 16918371 [PubMed - indexed for MEDLINE]
Unique atheroprotective property of azelnidipine, a dihydropyridine-based calcium antagonist.
Nakamura K, Yamagishi S, Inoue H.
Med Hypotheses. 2005;65(1):155-7. Epub 2005 Jan 28.
PMID: 15893134 [PubMed - indexed for MEDLINE]
Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E, DeFronzo RA.
Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):423-36. Review.
PMID: 16506274 [PubMed - indexed for MEDLINE]
Metabolic syndrome.
Reaven P.
J Insur Med. 2004;36(2):132-42. Review.
PMID: 15301226 [PubMed - indexed for MEDLINE]
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Woodman RJ, Chew GT, Watts GF.
Drugs. 2005;65(1):31-74. Review.
PMID: 15610050 [PubMed - indexed for MEDLINE]